New York City

New immune cell suspects in lupus

The findings could redirect lupus research and open the door to more precise therapies that avoid broad immune suppression.

$7M grant from NASA, Schmidt Sciences to upgrade arXiv

The funding will help arXiv – which is maintained and operated by Cornell Tech – finish migrating to cloud infrastructure and modernizing its code. 

Molecular switch could cause painful side effect of chemo

Chemotherapy activates a stress sensor in immune cells, which may help explain why many cancer patients experience debilitating pain as a side effect, according to Weill Cornell Medicine and Wake Forest University researchers.

Five questions for: James Grimmelmann

An August article by Grimmelman, co-authored with A. Feder Cooper, Ph.D. ’24, was cited in a landmark European court ruling against OpenAI on Nov. 11. 

Hypertension affects the brain much earlier than expected

Hypertension impairs blood vessels, neurons and white matter in the brain well before the condition causes a measurable rise in blood pressure, according to a new preclinical study from Weill Cornell Medicine investigators.

Cornell Tech launches pre-college Summer Innovation Intensives for future tech leaders

The three-week program is designed to give students a head start on college-level learning while tackling real-world challenges through technology.

Around Cornell

Johnson Cornell Tech MBA ranks No. 4 in entrepreneurship excellence

Startup bootcamps. Acquisitions. Millions in seed funding. Johnson Cornell Tech MBA graduates seize these opportunities and more.

Around Cornell

Celebrating the 50th Startup Cornell podcast at Eclectic Convergence

This episode features speakers and attendees recorded live during the Oct. 31 conference at Cornell Tech in New York City.

Around Cornell

Common-cold coronavirus could be key to a better COVID-19 vaccine

Prior exposure to coronaviruses that cause ordinary colds can boost the immune system’s ability to attack a vulnerable site on the COVID-19-causing coronavirus SARS-CoV-2, according to a study led by investigators at Weill Cornell Medicine.